The technology is suited for the formulation of nutraceuticals, prescription, and OTC drugs, including the branding of generics. In particular, the patent applications cover drug delivery devices that allow for linear, sustained-release of solutes with adjustable initial release kinetics $CWNM
(0)
(0)